Tuttiquotidiani is completely free. Every day we aggregate news from 100+ sources and generate original AI summaries for you. Help us keep the service running with a small donation, or become TQ Pro for just €1/month.

Donate now TQ Pro - 1€/mo

JM Financial sees up to 28% upside in Dr Reddy’s and Aurobindo Pharma. Should you buy?

Posted on September 16, 2026
By Business News Today
0 Views
1 min read

In brief

Generating AI summary…

JM Financial sees up to 28% upside in Dr Reddy’s and Aurobindo Pharma. Should you buy?

JM Financial retained Buy ratings on Dr Reddys Laboratories and Aurobindo Pharma, seeing up to 28% upside over the next 12 months. The brokerage expects stronger earnings growth, business diversification and new product launches to support both drugmakers.